pubmed-article:15151978 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:15151978 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:15151978 | lifeskim:mentions | umls-concept:C0030421 | lld:lifeskim |
pubmed-article:15151978 | lifeskim:mentions | umls-concept:C0047506 | lld:lifeskim |
pubmed-article:15151978 | lifeskim:mentions | umls-concept:C1522484 | lld:lifeskim |
pubmed-article:15151978 | lifeskim:mentions | umls-concept:C0036525 | lld:lifeskim |
pubmed-article:15151978 | lifeskim:mentions | umls-concept:C0243144 | lld:lifeskim |
pubmed-article:15151978 | lifeskim:mentions | umls-concept:C0085973 | lld:lifeskim |
pubmed-article:15151978 | lifeskim:mentions | umls-concept:C0007320 | lld:lifeskim |
pubmed-article:15151978 | lifeskim:mentions | umls-concept:C1547774 | lld:lifeskim |
pubmed-article:15151978 | pubmed:issue | 918 | lld:pubmed |
pubmed-article:15151978 | pubmed:dateCreated | 2004-5-20 | lld:pubmed |
pubmed-article:15151978 | pubmed:abstractText | Metaiodobenzylguanidine (MIBG) labelled with iodine-131 ((131)I) has become a well established therapeutic tool for inoperable metastastic tumours of paraganglioma. There are different pharmacological substances known to interfere with MIBG-uptake which may result in a false negative MIBG scan. We present the case of a 26-year-old male polytoxicomanic patient with metastatic paraganglioma, who underwent MIBG therapy. During earlier therapies, MIBG uptake in the metastatic lesions was very high. A post-therapeutic whole-body scan subsequent to recent (131)I-MIBG therapy failed to detect the vast majority of metastatic lesions-except for two. (18)F-fluorodeoxyglucose (FDG) positron emission tomography (PET) showed metastases with a similar distribution to the initial MIBG scan. The possible reasons for the discrepancy in the findings of the MIBG scans and the (18)F-FDG-PET scan are discussed with special emphasis on drug intake prior to MIBG administration, increased MIBG turn-over and unknown drug mixture interference with MIBG uptake. | lld:pubmed |
pubmed-article:15151978 | pubmed:language | eng | lld:pubmed |
pubmed-article:15151978 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15151978 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:15151978 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15151978 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15151978 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15151978 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15151978 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15151978 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15151978 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15151978 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:15151978 | pubmed:month | Jun | lld:pubmed |
pubmed-article:15151978 | pubmed:issn | 0007-1285 | lld:pubmed |
pubmed-article:15151978 | pubmed:author | pubmed-author:MenzelCC | lld:pubmed |
pubmed-article:15151978 | pubmed:author | pubmed-author:GrünwaldFF | lld:pubmed |
pubmed-article:15151978 | pubmed:author | pubmed-author:KranertW TWT | lld:pubmed |
pubmed-article:15151978 | pubmed:author | pubmed-author:BehrT MTM | lld:pubmed |
pubmed-article:15151978 | pubmed:author | pubmed-author:HamschoNN | lld:pubmed |
pubmed-article:15151978 | pubmed:author | pubmed-author:DöbertNN | lld:pubmed |
pubmed-article:15151978 | pubmed:author | pubmed-author:ZaplatnikovKK | lld:pubmed |
pubmed-article:15151978 | pubmed:author | pubmed-author:GotthardMM | lld:pubmed |
pubmed-article:15151978 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:15151978 | pubmed:volume | 77 | lld:pubmed |
pubmed-article:15151978 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:15151978 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:15151978 | pubmed:pagination | 525-7 | lld:pubmed |
pubmed-article:15151978 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
pubmed-article:15151978 | pubmed:meshHeading | pubmed-meshheading:15151978... | lld:pubmed |
pubmed-article:15151978 | pubmed:meshHeading | pubmed-meshheading:15151978... | lld:pubmed |
pubmed-article:15151978 | pubmed:meshHeading | pubmed-meshheading:15151978... | lld:pubmed |
pubmed-article:15151978 | pubmed:meshHeading | pubmed-meshheading:15151978... | lld:pubmed |
pubmed-article:15151978 | pubmed:meshHeading | pubmed-meshheading:15151978... | lld:pubmed |
pubmed-article:15151978 | pubmed:meshHeading | pubmed-meshheading:15151978... | lld:pubmed |
pubmed-article:15151978 | pubmed:meshHeading | pubmed-meshheading:15151978... | lld:pubmed |
pubmed-article:15151978 | pubmed:meshHeading | pubmed-meshheading:15151978... | lld:pubmed |
pubmed-article:15151978 | pubmed:meshHeading | pubmed-meshheading:15151978... | lld:pubmed |
pubmed-article:15151978 | pubmed:meshHeading | pubmed-meshheading:15151978... | lld:pubmed |
pubmed-article:15151978 | pubmed:meshHeading | pubmed-meshheading:15151978... | lld:pubmed |
pubmed-article:15151978 | pubmed:meshHeading | pubmed-meshheading:15151978... | lld:pubmed |
pubmed-article:15151978 | pubmed:meshHeading | pubmed-meshheading:15151978... | lld:pubmed |
pubmed-article:15151978 | pubmed:meshHeading | pubmed-meshheading:15151978... | lld:pubmed |
pubmed-article:15151978 | pubmed:year | 2004 | lld:pubmed |
pubmed-article:15151978 | pubmed:articleTitle | Case report: drug interference with MIBG uptake in a patient with metastatic paraganglioma. | lld:pubmed |
pubmed-article:15151978 | pubmed:affiliation | Department of Nuclear Medicine, Hospital of the J.W. Goethe-University, Frankfurt/Main, Germany. | lld:pubmed |
pubmed-article:15151978 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:15151978 | pubmed:publicationType | Case Reports | lld:pubmed |